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In a patient with a medical history of cancer, the most probable diagnosis of an 18FDG-
avid pulmonary mass combined with intracranial abnormalities on brain imaging is 
metastasized cancer. However, sometimes a differential diagnosis with an infectious 
cause such as aspergillosis can be very challenging as both cancer and infection are 
sometimes difficult to distinguish. Pulmonary aspergillosis can present as an infectious 
pseudotumour with clinical and imaging characteristics mimicking lung cancer. Even in 
the presence of cerebral lesions, radiological appearance of abscesses can look like 
brain metastasis. These similarities can cause significant diagnostic difficulties with a 
subsequent therapeutic delay and a potential adverse outcome. Awareness of this 
infectious disease that can mimic lung cancer, even in an immunocompetent patient, 
is important. We report a case of a 65-year-old woman with pulmonary aspergillosis 
disseminated to the brain mimicking metastatic lung cancer.
Keywords: lung cancer, lung neoplasms, brain metastasis, brain neoplasms, brain abscess, aspergillosis, 
differential diagnosis
Case DesCRIptIoN
A 65-year-old woman, never-smoker, was referred for a second opinion in January 2014 because of 
an abnormal computed tomography (CT) of the chest with a mass in the right lower lobe. Extensive 
evaluation in the referring hospital had not revealed a diagnosis. A clear overview of the medical 
disease history is demonstrated in a timeline (Figure 1). Her medical history consisted of a right-
sided mastectomy for breast cancer in 2006, with no adjuvant treatment indicated. On the staging 
18-fluordeoxyglucose positron emission tomography-computed tomography (18FDG-PET-CT) for 
the breast cancer in 2006 an asymptomatic, 30-mm diameter, lobulated 18FDG-negative solitary mass 
was seen in the right lower lobe. Bronchoscopic sampling for cytology and microbiological cultures 
showed neither proof of malignancy nor infection, and follow-up was chosen. Serial follow-up chest 
CTs up to December 2011 (total follow-up of 5 years) showed no change and follow-up was ended.
In August 2013, she was seen in the referring hospital because of a productive cough, dyspnea 
on exertion, tiredness, and weight loss since the last 3 months. There was no fever nor night sweats. 
18FDG-PET-CT revealed an intense 18FDG-avid mass in the right lower lobe, just next to the old 
pulmonary lesion, with intense hilar lymphadenopathy (Figure 2). Differential diagnosis consisted 
of malignancy (metastatic breast cancer or primary lung cancer) or infection. Bronchoscopic 
2013 2014
August 2013
Inial presentaon
at original hospital.
January 2014
Referral for second opinion at 
terary hospital with worsening
symptoms. Renewed analysis with
18FDG-PET-CT, bronchoscopy, 
mediasnoscopy.
September 2013
Inial work-up with CT, 18FDG-
PET-CT, bronchoscopy and
EBUS-TBNA at referring
hospital.
December 2011
Serial chest-CT 
showed no change of 
pulmonary mass, 
follow-up ended.  
October 2014
Construcon 
ventriculoperitoneal 
drainage.
March 2014
New symptomac
brain lesions, short 
hospitalisaon in 
referring hospital.
February 2014
Start therapy with
prednisone 1mg/kg/day + 
azithromycine.
May 2014
Clinical deterioraon and
hospitalisaon in terary
hospital. Skin biopsies of skin 
lesions, brain MRI suggesve for
abscesses, 18FDG-PET-CT with
growth of pulmonary mass.
June 2014
Cerebral biopsies 
of brain lesions. 
Start therapy with
voriconazole.
December 2014
Paent discharged.
2006
Right sided mastectomy for
breast cancer. Analysis of 18FDG-
negave solitary pulmonary
mass.
October 2013
VATS at referring
hospital. Start therapy
with prednisone
0,5mg/kg/day.  
FIGURe 1 | Timeline. Abbreviations: 18FDG, 18-fluordeoxyglucose; CT, computed tomography; VATS, video assisted thoracic surgery; 18FDG-PET-CT, 
18-fluordeoxyglucose positron emission tomography-computed tomography; EBUS-TBNA, endobronchial ultrasound with transbronchial needle aspiration; MRI, 
magnetic resonance imaging.
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FIGURe 2 | Continued
FIGURe 2 | Evolution of thoracic lesions. Top: Follow-up chest computed tomography (CT) in 2011 showing a right-sided lobulated pulmonary mass at the right 
lower lobe (3.0-cm diameter). Middle: CT (left) and fusion 18-fluordeoxyglucose positron emission tomography-computed tomography (18FDG-PET-CT) (right) in 
August 2013 shows an increase at the medial side of the mass and right hilar lymphadenopathy, with intense 18-fluordeoxyglucose (18FDG) uptake. Bottom: CT (left) 
and fusion 18FDG-PET-CT (right) in January 2014 showing further growth of the 18FDG-avid mass in the right lower lobe with hilar invasion and a mild 18FDG-avid 
subcarinal lymph node.
taBLe 1 | Diagnostic test results.
Date specimen Microbiological test results pathological test results
2006 Bronchial washing right 
lower lobe
Culture negative for bacteria and fungi
Auramine-rhodamine stain negative
No arguments for malignancy
August 15, 2013 Bronchial (brushing and) 
washing right lower lobe
Culture negative for bacteria and fungi
Auramine-rhodamine stain negative
Active inflammation
No arguments for malignancy
September 03, 2013 Computed tomography-
guided biopsy right lower 
lobe
NA Fibrosis with anthracosis and chronic inflammation
No arguments for malignancy
September 23, 2013 EBUS 10R NA Representative specimen of reactive lymph node 
without arguments for malignancy
October 29, 2013 Wedge resection apical 
segment right lower lobe
Culture negative for bacteria Fibrotic node with extensive chronic inflammation and 
bronchialization of the alveoli
No arguments for malignancy
No arguments for actinomyces infection
October 29, 2013 Urine Culture negative for bacteria and fungi NA
November 04, 2013 Blood Culture negative for bacteria and fungi NA
November 07, 2013 Urine Culture negative for bacteria and fungi NA
November 07, 2013 Wound fluid chest drain 
entrance
Sporadic S. aureus NA
January 20, 2014 Bronchial washing right 
lower lobe
Bacterial culture with commensal throat flora
Culture negative for fungi
Culture negative for actinomyces
Culture negative for nocardia
Auramine-rhodamine stain negative
Culture negative for mycobacteria
Active inflammation, sparse fungal hyphae and bacteria
No arguments for malignancy
January 30, 2014 Mediastinoscopy 4L and 7 NA Lymph node tissue without evidence of malignancy
Extensive sinushistiocytosis at lymph node station 7
March 31, 2014 Cerebrospinal tap NA No arguments for malignancy or infection
May 02, 2014 Skin biopsy Bacterial culture with coagulase-negative staphylococci
Fungal culture with Verticillium species and Aspergillus 
fumigatus
Extensive active inflammation with a lobular panniculitis 
and localization of fungal hyphae
No arguments for malignancy
May 02, 2014 Wound fluid skin biopsy Fungal culture with A. fumigatus NA
May 13, 2014 Serum Galactomannan negative
HIV 1 and HIV 2 antigen and immunoglobulin negative
Toxoplasma gondii IgG positive, IgM negative
Treponema pallidum immunoglobulin negative
NA
May 13, 2014 Blood (×2) Culture negative for bacteria and fungi NA
May 13, 2014 Urine Culture negative for bacteria and fungi NA
May 19, 2014 Serum Cryptococcus neoformans antigen negative NA
May 26, 2014 Serum Interferon-gamma release assay negative NA
June 02, 2014 Cerebral biopsy Aspergillus fumigatus Cerebral material with lytic cell remnants, active 
inflammation and presence of fungi (preference for 
Aspergillus)
NA, not available.
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sampling, CT-guided biopsy, and endobronchial ultrasound with 
transbronchial needle aspiration (EBUS-TBNA) revealed no 
malignancy and cultures were negative (Table 1). Transthoracic 
biopsy of the mass showed fibrosis and a chronic inflammation 
with histiocytic reaction. A video-assisted thoracoscopy with 
partial wedge resection of the pulmonary nodule was performed 
to obtain a definitive diagnosis and to rule out or confirm 
malignancy. Pathologic analysis of the resection specimen 
showed fibrosis with bronchiectasis, focal inflammation, and 
bronchiolisation of the alveoli, but no malignancy or microor-
ganisms (Table 1). With a diagnosis suggestive of cryptogenic 
organizing pneumonia, prednisone 0.5  mg/kg/day was initiated, 
FIGURe 3 | Brain magnestic resonance imaging in March 2014. T1-weighted 
image after gadolinium of the brain shows a small right frontal enhancing 
cerebral lesion.
4
Vanfleteren et al. Invasive Aspergillosis Mimicking Metastatic Cancer
Frontiers in Oncology | www.frontiersin.org June 2018 | Volume 8 | Article 188
although, due to steroid side-effects, limited in dose and dura-
tion (prednisone 0.5 mg/kg/day for 3 weeks followed by gradual 
tapering of the dose, total duration of prednisone treatment was 
2 months). Despite the steroids, her complaints worsened and 
the patient was referred to our tertiary center in January 2014. 
A new 18FDG-PET-CT showed progression of the 18FDG-avid 
lesion with extension into the mediastinum and lymph node sta-
tion 4R, with also mass effect on the right pulmonary artery and 
invasion of the left superior pulmonary vein (Figure 2). There 
was no evidence of extrathoracic lesions. Because of the invasive 
growth, malignancy was again in the differential diagnosis. In our 
hospital, renewed analysis was performed with bronchoscopy 
and mediastinoscopy, both without evidence of malignancy or 
infection (Table 1). Cytology of the bronchial aspirate showed 
sporadic hyphae (most probable Aspergillus), but without 
growth on culture and these were considered contamination 
or colonization. In March 2014, a multidisciplinary decision 
was made for a treatment with a higher dose of prednisone 
1  mg/kg/day in combination with macrolide antibiotic treat-
ment for 3  months (with slow tapering of the steroids) under 
suspicion of cryptogenic organizing pneumonia, but without 
clinical or radiologic response. Additional diagnostics were 
considered for the growing part of the lesion, but a CT-guided 
biopsy and surgical sampling were both not possible because of 
the risk of a massive bleeding. A follow-up 18FDG-PET-CT was 
scheduled to evaluate whether in the follow-up lesions would 
become better accessible for further diagnostic work-up. During 
the pulmonary work-up, in March 2014, the patient developed 
new complaints of progressive muscle weakness and sensibility 
loss of the right upper arm. She was hospitalized in the referring 
hospital. Additional brain imaging with magnetic resonance 
imaging (MRI) revealed multiple brain lesions in the cortex and 
watershed region, in the left corpus callosum, the left thalamus 
and partially in the right semioval center, which were considered 
brain metastases by the referring hospital (Figure 3). The MRI 
was revised by an experienced neuro-radiologist in our hospital 
who withheld a differential diagnosis of ischemia and metastasis. 
The brain lesions were not accessible for a biopsy because of the 
location and small size. Because of a poor clinical condition 
combined with a differential diagnosis of ischemia, no brain 
radiation was initiated. Patient was discharged after 1½-week 
hospitalization in the referring hospital. The neuro-oncology 
multidisciplinary team advised follow-up MRI 3 months later. 
On this MRI (May 2014), two lesions had enlarged significantly 
with marked perilesional edema but other lesions showed 
shrinkage (Figure 4). The radiologic appearance with restrictive 
diffusion of these lesions on diffusion-weighted images was sug-
gestive for (atypical) cerebral abscesses rather than metastases. 
The 18FDG-PET-CT showed further growth of the mass in the 
right lower lobe but without distant lesions. At the same time, the 
patient developed multiple ill-defined skin lesions. Because of 
her worse clinical condition, she was hospitalized in our tertiary 
hospital and cerebral and skin biopsies were performed: both 
showed marked inflammation and fungal hyphae with dichoto-
mous branching, suggestive for Aspergillus, there was no evi-
dence for malignancy (Table 1; Figures 5 and 6). Cultures of the 
wound fluid after skin biopsy also revealed Aspergillus (Table 1). 
The definitive diagnosis of proven invasive aspergillosis with 
pulmonary, mediastinal, cerebral, and skin involvement was 
made. Treatment with voriconazole was initiated with monitor-
ing of serum and cerebral spinal fluid (CSF) voriconazole levels. 
Because of progressive somnolence caused by hydrocephalus, 
repeated CSF drainage was necessary. Eventually, five neurosur-
gical procedures were needed for effective control of the infec-
tion and adequate drainage of the CSF, with in the end placement 
of an internal ventriculo-peritoneal drain. During treatment 
with voriconazole, there was a slow clinical recovery. Additional 
immunological analysis did not reveal an immunity disorder; 
there were normal titers of total IgG, IgM, IgG, and IgA, there 
were no complement abnormalities, screening for antinuclear 
antibodies and antineutrophil cytoplasmic antibodies was nega-
tive. Only the use of prednisone could be identified as immu-
nosuppressant factor which aided the further dissemination of 
this opportunistic infection. MRI of the brain performed after 
6  months of treatment showed marked improvement without 
evidence of hydrocephalus, the chest CT also improved. Patient 
was discharged in December 2014, 7  months after admission. 
She rehabilitated and made a near complete recovery.
DIsCUssIoN
We report our experience of the diagnostic dilemma in this patient 
with disseminated aspergillosis mimicking metastatic cancer. The 
FIGURe 4 | Brain magnetic resonance imaging in May 2014. There is an increase in size of the right frontal lesion with surrounding perilesional edema. T2-weighted 
image (left) demonstrates a hypo-intense rim with ring-enhancement after gadolinium (contrast-enhanced T1-weighted middle). At diffusion imaging (right panels) 
there is restricted diffusion in a part of the central area.
FIGURe 5 | Skin biopsy with presence of fungal hyphae. Periodic Acid Schiff 
stain on skin biopsy with fungal hyphae stained purple. Two fungal hyphae 
with dichotomous branching (diagnostic of Aspergillus) are depicted (arrows).
FIGURe 6 | Cerebral biopsy with presence of fungal hyphae. Hematoxylin 
and eosin stain on cerebral biopsy showing nectrotic tissue with moderate 
numbers of septate fungal hyphae with parallel walls. Two fungal hyphae with 
dichotomous branching (diagnostic of Aspergillus) are depicted (arrows).
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18FDG-avid pulmonary lesions were highly suspicious for malig-
nancy, especially in a patient with a history of breast cancer. Even 
in the presence of brain lesions, this suspicion remained high, as 
these brain lesions were first thought to be of metastatic origin. 
Eventually skin and cerebral biopsies and wound cultures did 
reveal the definitive diagnosis of disseminated invasive aspergillosis.
As a tertiary center, patients are frequently referred to our 
center with presumed lung cancer. In a retrospective analysis of 
a tertiary US hospital, the majority of such patients were proven 
to have a neoplastic process, only 1.3% had an infection (1). 
Pulmonary aspergillosis mimicking lung malignancy remains 
rare and only sporadic case reports are available in literature 
(1–7). In addition, symptoms (such as malaise, weight loss, 
cough, and hemoptysis) are non-specific and are overlapping 
those of a pulmonary neoplasm. Moreover, pulmonary aspergil-
losis can present as an infectious pseudotumour with radiological 
appearance and features similar and indistinguishable from lung 
cancer. When clinical and radiological features are suspected for 
malignancy, it is of utmost importance to strive for a definitive 
histopathological diagnosis. Many minimal invasive techniques 
such as bronchoscopy, CT-guided biopsy or EBUS-TBNA are 
available today to obtain this histopathological diagnosis. If not 
amenable or feasible or histopathological diagnosis cannot be 
obtained, a surgical approach might be necessary. The differential 
diagnosis can be very challenging and perseverance for diagnostic 
accuracy can be a hard and exhaustive exercise, which is dem-
onstrated in our case. Despite several attempts with noninvasive 
and invasive procedures to obtain a histopathological diagnosis, 
there was no clear evidence for malignancy or infection. Maybe in 
retrospect, the hyphae in the bronchial aspirate could have raised 
the suspicion for invasive aspergillosis, although this is very rare 
6Vanfleteren et al. Invasive Aspergillosis Mimicking Metastatic Cancer
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in an immunocompetent host such as our patient. In retrospec-
tive studies with immunocompromised patients with a diagnosis 
of invasive aspergillosis, cytological examination of bronchial 
washings had a sensitivity of 64.0%, specificity of 99.1%, and 
positive predictive value of 88.9% (8), However, predictive values 
depend upon the prevalence of disease in the population tested 
and our patient did not have an impaired immunity. Moreover, 
various species of Aspergillus spp. can colonize the airways, 
especially in patients with a chronic pulmonary disease, without 
any pathogenic consequences (as was thought to be the case in 
our patient), but they are also capable of causing several and 
severe types of disease as has been described in patients with 
bronchiectasis (9). Pathological features in the surgical specimen 
suggestive for cryptogenic organizing pneumonia made this 
case more complex. Furthermore, the suspicion of malignancy 
remained high, with further growth of her thoracic disease and 
development of brain lesions, suspicious for brain metastasis. 
Indeed, cerebral abscesses caused by Aspergillus spp. can also 
mimic cerebral metastasis. Contrast-enhanced CT and MRI are 
the modalities of choice for imaging of the brain when brain 
metastasis is suspected, with MRI more appropriate in character-
izing lesions (10–13). Although many MR features have been 
described, the differentiation between abscesses and necrotic 
brain tumors cannot be made in many cases with conventional 
MR imaging since its signal appearance can be similar to that 
of a cystic or necrotic tumor on conventional series (14, 15). 
A combination with diffusion-weighted MRI has been shown to 
be useful in the diagnosis of acute cerebral ischemia, malignancy, 
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(16). In our case, the dissociated response, the hypo-intense rim 
at T2-weighted imaging and the diffusion-weighted MRI aided 
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we could only identify two case resports (15, 17).
Coexistence of infectious pseudotumours and solid tumors 
at initial diagnosis have previously been reported (18), but are 
rather rare, especially in an immunocompetent patient. However, 
an endobronchial aspergilloma is thought to be able to infect 
endobronchial cancer lesions (19, 20). In general, most cases 
of coexisting infectious pseudotumours and lung cancer are 
rather a consequence of treatments with corticosteroids and/or 
chemotherapy.
CoNCLUsIoN
Pulmonary aspergillosis, even in the presence of cerebral 
abscesses, can present as an infectious pseudotumour with clini-
cal and imaging characteristics resembling lung malignancy. 
These clinical and radiological similarities can cause significant 
diagnostic difficulties, with a subsequent therapeutic delay and 
a potential adverse outcome. A definitive histopathological diag-
nosis should always be strived for when malignancy is suspected, 
but awareness that this infectious disease can mimic lung cancer 
even in immunocompetent patients is of great diagnostic and 
prognostic importance.
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